ACER’s Clinical Trials
ACER INSTITUTE IS ORGANIZING TWO CLINICAL TRIALS, WHITH ARE PENDING
WHAT IS A CLINICAL TRIAL ?
Clinical trials is a way to develop new ways to prevent, detect, diagnose, and treat cancer and other diseases.
It is also a way for advanced “terminal” patients to boost their hope and try an alternative approach, usually for free.
For researchers and clinicians, trials are important to determining the potential benefits and safety of investigational cancer therapies.
In the conventional oncology work, clinical trials are the last step before treatments can be commercialized. They come after the completion of basic lab research and testing. Clinical testing in patients helps to understanding how a particular therapy will perform and what kinds of side effects may occur.
FOUR CLINICAL TRIAL PHASES
Phase I trials are the first studies to test the safety aspect of a new drug, drug combination, supplement or medical procedure.
Phase II trials evaluate drug or medical intervention effectiveness and usually involve more participants than phase I studies.
Phase III trials are designed to compare a new treatment to one or more standard treatments and are usually randomized, meaning participants are randomly divided into treatment groups and not told until the study is over whether they received a standard treatment or the new treatment.
Phase IV trials are also known as post-marketing studies. These trials provide “real-world” data on the therapy.
Because new trials are continually getting underway, your oncologist may not be aware of all the studies available for patients with your specific type and stage of cancer. If you are interested in finding which clinical trials might be right for you, resources such as ClinicalTrials.gov are available. ClinicalTrials.gov is a registry of all publicly and privately supported clinical studies conducted around the world.
Before searching for a clinical trial, it is important to know the details of your cancer diagnosis, such as your cancer type and location; tumor size (if a solid tumor); cancer stage; and previous cancer treatments, if any.
Decades of cancer research have established that people from different races and ethnicities have differences in their susceptibilities to cancer, and there are differences in the way they respond to different treatments. Therefore, it is imperative that people of different races and ethnicities participate in clinical trials to help researchers identify appropriate treatment options.
In August 2014, the Food and Drug Administration put forth an action plan to increase participation by women, minorities, and older people in clinical trials. The goal of this plan is to improve the data quality on minority participation, identify barriers to minority enrollment in clinical trials and employ strategies to encourage greater participation, and make demographic subgroup data more available and transparent.
LIMITATION OF CONVENTIONAL CLINICAL TRIALS
In addition to their high costs, in the conventional system, the clinical trial process can take 5 to 10 years, and by that time, cancer research usually has made that clinical trial object obsolete, this is one of the reasons why the majority of clinical trials are stopped during their course or not followed through. Furthermore, much in hoslistic oncology works via health interventions which can not be put in a randomized double blind trial (Phase 3) because the patient knows what she or he is doing (eg, heat therapy, juicing, exercises etc).
ACER’S PENDING PROPOSED NEW TYPE OF CLINICAL TRIAL
For all of these reasons, ACER Institute has proposed two clinical trials without randomization and without Phase One, given the lack of danger from these non invasive methods. We are therefore simply accepting a certain amount of patients who will upregulate the anti cancer genes (tumor suppression genes among others) and down regulate the cancer genes (like Ras, or Her 2 +) via Holistic oncology, meaning “Lifestye medicine” which includes nutrition, exercises, meditation, education, breathing, oxygenation, heat among other techniques that can be learned at the Pyrenean Holistic Wellbeing Center.